Literature DB >> 25445825

Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy.

Mireia Gascon1, Maribel Casas2, Eva Morales3, Damaskini Valvi2, Ana Ballesteros-Gómez4, Noelia Luque4, Soledad Rubio4, Núria Monfort5, Rosa Ventura6, David Martínez2, Jordi Sunyer3, Martine Vrijheid2.   

Abstract

BACKGROUND: There is growing concern that prenatal exposure to bisphenol A (BPA) and phthalates, which are widely used in consumer products, might affect susceptibility to infections and the development of allergy and asthma in children, but there are currently very few prospective studies.
OBJECTIVE: We sought to evaluate whether prenatal exposure to BPA and phthalates increases the risk of respiratory and allergic outcomes in children at various ages from birth to 7 years.
METHODS: We measured BPA and metabolites of high-molecular-weight phthalates, 4 di-(2-ethylhexyl) phthalate (DEHP) metabolites (Σ4DEHP) and mono-benzyl phthalate (MBzP), and 3 low-molecular-weight phthalate (LMWP) metabolites (Σ3LMWP) in urine samples collected during the first and third trimesters in pregnant women participating in the Infancia y Medio Ambiente-Sabadell birth cohort study. The occurrence of chest infections, bronchitis, wheeze, and eczema in children was assessed at ages 6 and 14 months and 4 and 7 years through questionnaires given to the mothers. Atopy (specific IgE measurement) and asthma (questionnaire) were assessed at ages 4 and 7 years, respectively.
RESULTS: The relative risks (RRs) of wheeze (RR, 1.20; 95% CI, 1.03-1.40; P = .02), chest infections (RR, 1.15; 95% CI, 1.00-1.32; P = .05), and bronchitis (RR, 1.18; 95% CI, 1.01-1.37; P = .04) at any age increased for each doubling in concentration of maternal urinary BPA. Σ4DEHP metabolites were associated with the same outcomes (wheeze: RR, 1.25; 95% CI, 1.04-1.50, P = .02; chest infections: RR, 1.15; 95% CI, 0.97-1.35; P = .11; bronchitis: RR, 1.20; 95% CI, 1.01-1.43; P = .04). MBzP was associated with higher risk of wheeze (RR, 1.15; 95% CI, 1.00-1.33; P = .05). The risk of asthma at age 7 years was also increased with increasing prenatal BPA, Σ4DEHP, and MBzP exposure. There were no other exposure-outcome associations.
CONCLUSIONS: Prenatal exposure to BPA and high-molecular-weight phthalates might increase the risk of asthma symptoms and respiratory tract infections throughout childhood.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bisphenol A; asthma; atopy; bronchitis; chest infections; children; eczema; phthalates; specific IgE; wheeze

Mesh:

Substances:

Year:  2014        PMID: 25445825     DOI: 10.1016/j.jaci.2014.09.030

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  50 in total

1.  Prenatal exposure to bisphenol A and risk of allergic diseases in early life.

Authors:  Aifen Zhou; Huailong Chang; Wenqian Huo; Bin Zhang; Jie Hu; Wei Xia; Zhong Chen; Chao Xiong; Yaqi Zhang; Youjie Wang; Shunqing Xu; Yuanyuan Li
Journal:  Pediatr Res       Date:  2017-01-31       Impact factor: 3.756

2.  Assessment of recent developmental immunotoxicity studies with bisphenol A in the context of the 2015 EFSA t-TDI.

Authors:  Ellen V S Hessel; Janine Ezendam; Fleur A van Broekhuizen; Betty Hakkert; Jamie DeWitt; Berit Granum; Laurence Guzylack; B Paige Lawrence; Andre Penninks; Andrew A Rooney; Aldert H Piersma; Henk van Loveren
Journal:  Reprod Toxicol       Date:  2016-06-25       Impact factor: 3.143

3.  Associations between prenatal maternal urinary concentrations of personal care product chemical biomarkers and childhood respiratory and allergic outcomes in the CHAMACOS study.

Authors:  Kimberly Berger; Brenda Eskenazi; John Balmes; Nina Holland; Antonia M Calafat; Kim G Harley
Journal:  Environ Int       Date:  2018-10-04       Impact factor: 9.621

4.  Early life exposure to phthalates in the Canadian Healthy Infant Longitudinal Development (CHILD) study: a multi-city birth cohort.

Authors:  Garthika Navaranjan; Tim K Takaro; Amanda J Wheeler; Miriam L Diamond; Huan Shu; Meghan B Azad; Allan B Becker; Ruixue Dai; Shelley A Harris; Diana L Lefebvre; Zihang Lu; Piush J Mandhane; Kathleen McLean; Theo J Moraes; James A Scott; Stuart E Turvey; Malcolm R Sears; Padmaja Subbarao; Jeffrey R Brook
Journal:  J Expo Sci Environ Epidemiol       Date:  2019-10-22       Impact factor: 5.563

Review 5.  The effects of environmental chemicals on renal function.

Authors:  Anglina Kataria; Leonardo Trasande; Howard Trachtman
Journal:  Nat Rev Nephrol       Date:  2015-06-23       Impact factor: 28.314

6.  Bisphenol A Activates an Innate Viral Immune Response Pathway.

Authors:  Mark L Sowers; Hui Tang; Bing Tian; Randall Goldblum; Terumi Midoro-Horiuti; Kangling Zhang
Journal:  J Proteome Res       Date:  2019-12-27       Impact factor: 4.466

7.  Associations of prenatal environmental phenol and phthalate biomarkers with respiratory and allergic diseases among children aged 6 and 7 years.

Authors:  Jessie P Buckley; Lesliam Quirós-Alcalá; Susan L Teitelbaum; Antonia M Calafat; Mary S Wolff; Stephanie M Engel
Journal:  Environ Int       Date:  2018-03-20       Impact factor: 9.621

8.  Prenatal exposure to bisphenol-A is associated with Toll-like receptor-induced cytokine suppression in neonates.

Authors:  Sui-Ling Liao; Ming-Han Tsai; Shen-Hao Lai; Tsung-Chieh Yao; Man-Chin Hua; Kuo-Wei Yeh; Chi-Hsin Chiang; Shih-Yin Huang; Jing-Long Huang
Journal:  Pediatr Res       Date:  2015-11-16       Impact factor: 3.756

9.  Juvenile Toxicology: Relevance and Challenges for Toxicologists and Pathologists.

Authors:  Amera K Remick; Natasha R Catlin; Erin M Quist; Thomas J Steinbach; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2015-07-27       Impact factor: 1.902

Review 10.  The Impact of Bisphenol A and Phthalates on Allergy, Asthma, and Immune Function: a Review of Latest Findings.

Authors:  Lacey Robinson; Rachel Miller
Journal:  Curr Environ Health Rep       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.